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INTRODUCTION
Endometriosis is implantation of endometrium-like
tissue (stroma and glands) outside of the uterine
cavity, inducing chronic inflammation. The process
can affect all organs, but primarily encountered in
pelvic organs, including the ovaries.1-4 Most com-
monly, the complaints of endometriosis patients
are pain and infertility.5,6
Abstract
Objective: To compare serum Anti Müllerian Hormone (AMH) le-
vels in infertile women with and without endometriosis, and to de-
termine the mean levels of serum AMH in every stage of endo-
metriosis.
Method: We performed a cross-sectional study. Sixty-eight subjects
who have undergone laparoscopy and fulfilled both inclusion and
exclusion criteria are recruited consecutively. They are divided into
two groups, namely group with endometriosis and without en-
dometriosis. Blood samples are taken from each subject before la-
paroscopy, where serum AMH levels are then measured. The differ-
ence in mean levels of each group are tested with Mann-Whitney
test.
Result: The mean levels of serum AMH were significantly lower in
the endometriosis group than those in the group without endo-
metriosis (2.30 1.8 ng/ml vs 3.75 2.13 ng/ml; p=0.005). Using
Kruskal-Wallis test, it was found that there was a statistically signifi-
cant difference among endometriosis groups based on the severity
of endometriosis. There was no significant difference in the mean se-
rum AMH levels between the minimal-mild endometriosis group
and without endometriosis group (p=0.34), but the mean levels of
serum AMH were significantly lower in the moderate-severe en-
dometriosis compare to the group without endometriosis (p<0.005).
Conclusion: The mean levels of serum AMH in infertile women with
endometriosis were significantly lower than those in women with-
out endometriosis. There was no significant difference in the mean
serum AMH levels in minimal-mild endometriosis group and those
without endometriosis; while in moderate-severe endometriosis
group, it was significantly lower than in the group without endo-
metriosis.
[Indones J Obstet Gynecol 2014; 4: 188-192]
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Abstrak
Tujuan: Membandingkan rerata kadar AMH serum pada perempuan
infertil dengan dan tanpa endometriosis, serta untuk mengetahui
rerata kadar AMH serum pada tiap derajat endometriosis.
Metode: Kami melakukan penelitian potong lintang (cross sectional).
Enam puluh delapan subjek yang menjalani laparoskopi dan me-
menuhi kriteria inklusi dan eksklusi direkrut secara konsekutif dan
dibagi menjadi dua kelompok yang sama besar, yakni kelompok en-
dometriosis dan tanpa endometriosis. Sampel darah dari masing-
masing subjek diambil sebelum dilakukan laparoskopi, kemudian di-
ukur kadar AMH serum. Perbedaan rerata masing-masing kelompok
diuji dengan uji Mann-Whitney.
Hasil: Rerata kadar AMH serum pada kelompok endometriosis secara
signifikan lebih rendah dibandingkan dengan kelompok tanpa en-
dometriosis (2,30 1,8 ng/ml vs 3,75 2,13 ng/ml; p=0,005). Menggu-
nakan uji Kruskal-Wallis, ditemukan perbedaan yang bermakna se-
cara statistik pada subjek kelompok endometriosis berdasarkan dera-
jat endometriosis (p=0,005). Tidak ditemukan perbedaan kadar AMH
serum yang bermakna pada kelompok endometriosis minimal-ringan
dengan kelompok tanpa endometriosis (p=0,34), sedangkan pada
kelompok endometriosis sedang-berat rerata kadar AMH serum se-
cara signifikan lebih rendah dibanding kelompok tanpa endometriosis
(p<0,005).
Kesimpulan: Rerata kadar AMH serum pada perempuan infertil de-
ngan endometriosis lebih rendah dibandingkan dengan yang tanpa
endometriosis, dan secara statistik terdapat perbedaan bermakna. Ti-
dak ditemukan perbedaan kadar AMH serum yang bermakna pada
kelompok wanita infertil dengan endometriosis derajat minimal-
ringan dibandingkan dengan kelompok wanita infertil tanpa endo-
metriosis, tetapi ditemukan perbedaan kadar AMH serum yang ber-
makna antara kelompok wanita infertil dengan endometriosis derajat
sedang-berat dan kelompok wanita infertil tanpa endometriosis.
[Maj Obstet Ginekol Indones 2014; 4: 188-192]
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The hypothesis that endometriosis causes infer-
tility or decreased fertility remains a controversy.
It has been shown that the prognosis of assisted
reproductive technique in endometriosis patients
is worse than that in patients with tubal occlu-
sion.7-9 One of the mechanisms causing infertility
in endometriosis is the change in folliculogenesis
resulting in ovulatory dysfunction and poor oocyte
quality.8 To evaluate the ovarian follicular status,
classically, early follicular phase serum FSH, in-
hibin-B, and E2 levels have to be measured. How-
ever, the utility of those measurements and their
clinical value is still limited.10,11 A new way to
evaluate the ovarian follicular status is by measur-
ing Anti Müllerian Hormone (AMH).
Anti Müllerian Hormone (AMH) is produced by
small, early anthral follicles and is more strongly
associated with the number of small anthral folli-
cles compared to FSH, E2, and even inhibin-B levels.
In vivo and in vitro studies showed that AMH has
an inhibitory effect on primordial follicular recruit-
ment and decreases the sensitivity of follicles for
the FSH-dependent selection for dominance. Be-
side its functional role in the ovary, serum AMH
level serves as an excellent candidate marker of
ovarian reserve.11-13
Hendarto found that infertile women with endo-
metriosis have an increase in TNF-  and hyaluro-
nan levels with a decrease in GDF-9 level, causing
disturbance in folliculogenesis and low oocyte qua-
lity.14 In another study, Kusuma found that mean
level of serum AMH in postpartum women with en-
dometriosis is lower than the control group (non-
endometriosis women).15 The mean level of serum
AMH in baby girls born from mother with endo-
metriosis was clinically lower than that in the con-
trol group (baby girls with non-endometriosis mo-
ther). This study showed that there was a correla-
tion between endometriosis and the low level of
AMH, and the decrease of AMH level begins in the
postnatal period.
The aims of this study are to compare the levels
of serum AMH in infertile women with and with-
out endometriosis, and also to determine the mean
serum AMH levels in different stages of endome-
triosis.
METHODS
Design
A cross-sectional study was conducted at the Infer-
tility Clinic and Yasmin Clinic at Dr. Cipto Mangun-
kusumo Hospital and Sam Marie Wijaya Invasive
Clinic, Jakarta, from January 2011 until June 2013.
Patients were consecutively recruited and divided
into two groups: group I (study group) consisting
of infertile patients with endometriosis as proven
by laparoscopy (n=38) and group II (control group)
consisting of infertile patients without endometrio-
sis (n=30). All patients underwent routine explora-
tion and laparoscopy for the investigation of infer-
tility and as a part of this study. Endometriosis sta-
ging was performed according to the classification
of the American Society for Reproductive Medicine
1996.
All patients younger than 35 years old who were
infertile and agreed to be included in the study were
recruited. The following exclusion criteria were ap-
plied: body mass index (BMI) >30 kg/m2; history of
ovarian surgery, including ovarian drilling and/or
uterine artery ligation, history of cancer or having
therapy that can affect ovarian function, history of
severe pelvic infection (frozen pelvis) and patients
with previous hormonal therapy for endometriosis.
Venous blood samples were collected (3 ml) from
each patient before laparoscopic surgery, to measure
the serum AMH levels. AMH levels were measured
using a commercial enzyme-linked immunosorbent
assay (ELISA) kit according to the manufacturer’s in-
struction.
All data were collected in a computerized data-
base. Statistical analysis was performed using SPSS
20.0 for Windows. Data were presented as mean, me-
dian (minimal-maximal range), and standard devia-
tion. Independent t-test and ANOVA were used if the
sample was normally distributed. Otherwise, Mann-
Whitney and Kruskal-Walls tests will be used.
We calculated that a sample size of more than 22
subjects in each group would allow us to show a dif-
ference in AMH level between subject and control of
0.76 ng/ml9 with type I error of 0.05 and type II error
of 0.2. A p-value <0.05 was considered as statistically
significant.
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RESULTS
In the endometriosis group, there were 6 patients
(15.8%) with stage 1 endometriosis (minimal en-
dometriosis), 13 patients (34.2%) with stage 2 en-
dometriosis (mild endometriosis), 11 patients
(28.9%) with stage 3 endometriosis (moderate en-
dometriosis), and 8 patients (21.1%) with stage 4
endometriosis (severe endometriosis). In the con-
trol group there were 21 patients (70%) with tubal
occlusion or hydrosalphinx, 6 patients (20%) with
subserosal myoma, and 3 patients (10%) with en-
dometrial polyp.
The baseline characteristics of both groups were
comparable. The median age in the study group
was 33 (range = 23-35) years and 32.5 (range =
25-35) years for the control group (p>0.05). In ad-
dition, BMI (22.4 2.06kg/m2 for the study group
and 23.1 2.04kg/m2 for the controls) were also
similar between groups.
As shown in Table 1, the mean serum AMH lev-
els were lower in the endometriosis group than in
the control group and it was found to be statisti-
cally significant (2.30 1.8 ng/ml vs 3.75 2.13 ng/
ml; p = 0.005).
Using Kruskal-Wallis test, it was found that there
was a statistically significant difference of serum
AMH levels among endometriosis subgroups based
on the stages of endometriosis.
We divided the endometriosis group into mini-
mal-mild endometriosis and moderate-severe en-
dometriosis and compared the serum AMH levels
with the control group. There was no significant
difference in the mean serum AMH level between
the group with minimal-mild endometriosis and
the control group (3.12   1.97 ng/ml vs 3.75   2.13
ng/ml, p=0.34). Meanwhile, the mean serum AMH
level was significantly lower in the moderate-se-
vere endometriosis compared to the control group
(1.48   1.30 ng/ml vs 3.75   2.13 ng/ml, p<0.005).
DISCUSSION
In this study, we found that patients with en-
dometriosis have lower serum AMH level than
those in the control group, and AMH level de-
creases in relation to the severity of endometriosis.
Our finding was concordant with results from a
study by Streulli et all.16 They found that the dif-
ference in serum AMH levels between women in
endometriosis and controls did not reach signifi-
cance (3.6 3.1 ng/ml vs 4.1 3.4 ng/ml, p=0.06).
The AMH level was only found to be significantly
lower in patients aged >40 years old or patients
with history of surgery for endometriosis cyst
(either laparotomy or laparoscopy).
Table 1. Serum AMH Levels in Infertility Groups (ng/ml)
Serum AMH levels
Infertility Groups
p*
With Endometriosis (n = 38) Without Endometriosis (n = 30)
Mean   SD 2.30   1.8 3.75   2.13 0.005
Median (range) 2.35 (0.16-7.20) 3.0 (0.71-8.30)
* Mann-Whitney test
Table 2. Serum AMH Levels in Endometriosis Group, based on Stages of
     Endometriosis (ng/ml).
Stage of Endometriosis n Mean   SD Median (range) p*
AMH Minimal 6 4.13   2.05 3.3 (230-9.25) 0.005
Mild 13 2.65   1.82 2.6 (0.41-7.0)
Moderate 11 1.97   1.30 2.3 (0.2-4.18)
Severe 8 0.82   1.04 0.2 (0.16-2.8)
*Kruskal-Wallis test.
Post-hoc test with ANOVA-LSD: minimal vs moderate endometriosis p=0.007; minimal vs
severe endometriosis p<0.001; moderate vs severe endometriosis p=0.048
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In women, serum AMH significantly declines
with increasing age. After reaching 37 years old,
the number of oocytes is reduced with decreased
fertility potential, even when menstrual cycles are
still regular. This condition will continue until me-
nopause, when the remaining follicles were appro-
ximated to be only 1000 follicles.17-19
In this study we discovered that the mean serum
AMH levels is decreasing in relation with the se-
verity of endometriosis. After we did post-hoc
analysis and divided them into 3 groups (the mild
endometriosis is considered to be the level bet-
ween minimal and moderate endometriosis), we
found that there are significantly different AMH
levels between minimal and moderate endome-
triosis, minimal and severe endometriosis, and also
between moderate and severe endometriosis. This
result is similar to the study conducted by Youssef
and Anwar.20 They concluded that AMH levels
could be used as a sensitive marker to predict stage
of endometriosis in infertile women.
We divided the endometriosis group into mini-
mal-mild endometriosis and moderate-severe en-
dometriosis and compared the serum AMH levels
with the group without endometriosis. There was
no difference in the mean serum AMH levels bet-
ween groups with minimal-mild endometriosis and
without endometriosis, but the mean serum AMH
level was lower in the group with moderate-severe
endometriosis compared to the group without en-
dometriosis and it was statistically significant. This
finding shows that not all of infertile women with
endometriosis become poor responder. Moreover,
it should be considered that in infertile women
with minimal-mild endometriosis it is not neces-
sary to provide any intervention since the serum
AMH level is not significantly different from the
levels in infertile women without endometriosis.
This result is contradictory with the study con-
ducted by Lemos et al9, where they found that the
serum AMH levels in infertile women with mini-
mal-mild endometriosis were significantly lower
than serum AMH levels in infertile women with
tubal factor. They also found that the number of
basal anthral follicles in both groups were compa-
rable. The rationale for this result was the fact that
patients with minimal/mild endometriosis had a
more heterogeneous follicular cohort, with a mean
follicular diameter larger than that of patients with
tubal obstruction.
Moreover Shebl et al16 found that the serum
AMH levels in minimal-mild endometriosis did not
show any difference from serum AMH levels in in-
fertile women without endometriosis (3.28 1.93
ng/ml vs 3.44 2.06 ng/ml, p=0.61). In moderate-
severe endometriosis, however, the serum AMH
levels was significantly lower (2.38 1.83 ng/ml vs
3.58 2.46 ng/ml, p<0.0001). Further, Campos et
al21 found that follicular-fluid AMH concentration
in infertile women with minimal-mild endometrio-
sis was similar to the concentration in infertile wo-
men without endometriosis (1.8 0.3 ng/ml vs
1.5 0.1 ng/ml, mean difference=0.33 ng/ml, 95%
CI -0.21 to 0.88). AMH in the follicular fluid plays
an important role in oocyte development and fer-
tilization. High levels of follicular fluid AMH had a
positive correlation with successful oocyte fertili-
zation; this result showed that follicular fluid AMH
plays a role in oocyte development and fertilization
stimulated by exogenous FSH.
When serum AMH is compared to follicular
AMH, some authors have demonstrated a positive
correlation between them, indicating that periphe-
ral AMH concentrations are modulated not only by
the number of follicles, but also by the individual
ability of the follicle itself to produce AMH.22 This
mechanism is not applicable to endometriosis pa-
tients, considering that these patients represent a
heterogeneous follicular cohort as has already
been shown.12
In conclusion, the mean serum AMH levels in in-
fertile women with endometriosis were significan-
tly lower than that in the group without endome-
triosis. There was no difference between the mean
levels of serum AMH in minimal-mild endometrio-
sis group and the levels in women without endo-
metriosis, while in the moderate-severe endome-
triosis group, serum AMH level was significantly
lower than the group without endometriosis.
REFERENCES
1. D’Hooghe TM, Hill JA. Endometriosis. In: Berek JS. (ed.)
Berek and Novak’s Gynecology. Philadelphia: Lippincott
Williams and Wilkins; 2007: 1137-85.
2. Speroff L, Glass RH, Kase NG. Endometriosis. In: Clinical
Gynecologic Endocrinology and Infertility. 7th ed. Philadel-
phia: Lippincott Williams and Wilkins; 2005: 1103-34.
3. Gazvani R, Templeton A. New considerations for the patho-
genesis of endometriosis. Int J Gynecol Obstet 2002; 76:
117-26.
4. Jacoeb TZ, Hadisaputra W. (eds). Penanganan Endometrio-
sis. Panduan Klinis dan Algoritme. Jakarta: CV. Sagung Seto;
2009.
Vol 2, No 4
October 2014 Ovarian reserve in infertile women  191
5. American Society for Reproductive Medicine. Endometrio-
sis and infertility. Fertil Steril 2006; 86 (5 Suppl 1): 156-60.
6. Baziad A. Endometriosis. Endokrinologi Ginekologi. Jakarta:
Media Aesculapius FKUI; 2008.
7. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of en-
dometriosis. Fertil Steril 2001; 75(1): 1-10.
8. Cahill DJ. What is the optimal medical management of in-
fertility and minor endometriosis? Analysis and future pros-
pects. Hum Reprod 2002; 17(5): 1135-40.
9. Lemos NA, Arbo E, Scalco R, et al. Decreased anti-Müllerian
hormone and altered ovarian follicular cohort in infertile
patiens with mild/minimal endomeriosis. Fertil Steril 2008;
89(5): 1064-8.
10. Van Rooij IAJ, Broekmans FJM, Velde ERT, et al. Serum anti-
Müllerian hormone levels: a novel measure of ovarian re-
serve. Hum Reprod 2002; 17(12): 3065-71.
11. Ebner T, Sommergruber M, Moser M, et al. Basal level of
anti-Müllerian hormone is associated with oocyte quality in
stimulated cycles. Hum Reprod 2006; 21(8): 2022-6.
12. Gruijters MJG, Visser JA, Durlinger ALL, et al. Anti-Müllerian
hormone and its role in ovarian function. Mol Cel Endocri-
nol 2003; 211: 85-90.
13. Mahmood TA, Templeton A. Folliculogenesis and ovulation
in infertile women with mild endometriosis. Hum Reprod
1991; 6(2): 227-31.
14. Hendarto H. Profil Kadar TNF , GDF-9 dan Hyaluronan
pada Gangguan Folikulogenesis sebagai Gambaran Penu-
runan Kualitas Oosit Pasien Endometriosis yang Infertil.
Surabaya: Universitas Airlangga; 2007.
15. Kusuma N. Perbandingan Kadar Anti-Müllerian Hormone
(AMH) darah tali pusat bayi baru lahir perempuan antara
bayi dari ibu dengan endometriosis dan ibu tanpa endo-
metriosis. Tesis Subspesialisasi FER. Universitas Indonesia;
2011.
16. Shebl O ET, Sommergruber M, Sir A, et al. Anti-Müllerian hor-
mone serum levels in women with endometriosis: a case-con-
trol study. Gynecol Endocrinol 2009; 25 (11): 713-6.
17. Sattar AAT. Ovarian Reserve. ASJOG. 2005; 2: 338-43.
18. Visser JA, Themmen APN. Anti-Müllerian hormone and fol-
liculogenesis. Mol Cel Endocrinol 2005; 234: 81-6.
19. Coccia ME, Rizello F. Ovarian Reserve. Ann N Ac Sci. 2008;
1127: 27-30.
20. Anwar D, Yousef M. Anti-Müllerian hormone as a marker
for severity of endometriosis: A pilot study. EBWHJ 2011;
1(2): 61-3.
21. Campos DV, C Andreoli, AC Martins, et al. Follicular-fluid
anti-Müllerian hormone concentration is similar in patients
with endometriosis compared with non-endometriotic pa-
tients. Reprod Bio Med Online 2010; 21: 470-3.
22. Fanchin R, Schonauer LM, Righini C, et al. Serum anti-
Müllerian hormone is more strongly related to ovarian fol-
licular status than serum inhibin B, estradiol, FSH, and LH
on day 3. Hum Reprod 2003; 18(2): 323-7.
Indones J
192  Harharah et al Obstet Gynecol
